From: Protease inhibitor concentrations in the saliva of individuals experiencing oral dryness
 | Control group (n = 21) | Oral dryness group (n = 9) |
---|---|---|
Age | 45.8 ± 6.6 | 45.1 ± 5.9 |
Saliva flow rate (g/min) | 0.29 ± 0.09 | 0.25 ± 0.08 |
Salivary protein concentration (mg/mL) | 0.74 ± 0.46 | 0.62 ± 0.30 |
Salivary bacterial counts (logCFU/mL) | 6.19 ± 0.48 | 6.30 ± 0.39 |
Oral rinsing solution turbidity (OD660) | 0.25 ± 0.13 | 0.33 ± 0.10 |
Mucosal detachment (mg) | 7.7 ± 2.5 | 9.5 ± 2.7 |
DMFT | 12.0 ± 6.6 | 12.4 ± 6.5 |
GI | 0.93 ± 0.15 | 1.06 ± 0.10* |
BOP | 0.08 ± 0.08 | 0.16 ± 0.10* |
PD (mm) | 2.50 ± 0.18 | 2.66 ± 0.28 |
OHI | 1.78 ± 0.91 | 2.11 ± 0.77 |
WTCI | 1.95 ± 2.29 | 3.44 ± 2.46 |
VSC (ppb) | 229 ± 144 | 228 ± 106 |